Surgery Partners,Inc. (NASDAQ:SGRY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
(b) On February16, 2018, Michael T. Doyle resigned from the Board of Directors of Surgery Partners,Inc. (the “Company”) after more than a decade of service to the Company. During his tenure, Mr.Doyle was instrumental in successfully building Surgery Partners from just a few Ambulatory Surgery Centers to one of the leading providers of outpatient surgical procedures in the country. We thank Mr.Doyle for his many years of leadership and for continuing to serve on the Board of Directors to help ensure a successful transition. We wish Mr.Doyle continued success in his future endeavors.
About Surgery Partners,Inc. (NASDAQ:SGRY)
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to management service agreements. The Company’s optical services segment consists of an optical laboratory, an optical products group purchasing organization and a marketing business. The Company’s optical laboratory manufactures eyewear, while its optical product purchasing organization negotiates volume buying discounts with optical product manufacturers.